导读肺挫伤是指胸部创伤后对肺实质造成的直接或间接的损伤，肺挫伤后血液和其他体液在肺组织内积聚，过多的液体使通气/血流比失衡，从而导致缺氧。肺挫伤是引起急性肺损伤(acute lung injury, ALI)、急性呼吸窘迫综合征(acute ...

While HMPV is a respiratory infection, health experts have warned that it can damage your kidneys and also increase your risk ...

This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...

A groundbreaking study reveals medical ozone therapy as a potential game-changer in improving survival rates and lung ...

Background: Over the last decade, several studies have suggested that survival rates for patients with acute lung injury (ALI) or ARDS may have improved. We performed a systematic analysis of the ...

this innovative approach could significantly improve survival rates and lung function in preclinical models, offering hope ...

ARDS survival was significantly predicted by improvement in the P/F ratio in patients who underwent 3 periods of prone ...

Since the virus SARS-CoV-2 was identified as the cause of the COVID-19 pandemic, scientists have focused on finding drugs and vaccines to treat and prevent disease. No targeted therapeutics ...

“Although the basis for this difference is potentially pathobiology specific to lung development and ARDS propagation, the nonlinear association of age and mortality may also reflect the ...

ARDS is a lung condition where the patient suffers from sudden breathlessness, low blood oxygen levels and lung inflammation that could progress to respiratory failure. Molgramostim is an immune ...

CK-0802 is under clinical development by Cellenkos and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.